Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
Nanoscale|March 21, 2025
Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancerSilvia Vanni, Tania Mariastella Caputo, Angela Maria Cusano, et al.
Cancers|January 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center ExperienceAlessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra, et al.
Tumori|August 20, 2009
Multidisciplinary approach to the treatment of bone metastases: Osteo-Oncology Center, a new organizational modelToni Ibrahim, Emanuela Flamini, Laura Fabbri, et al.
Neuroendocrinology|August 31, 2022
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT StudyPiero Ferolla, Alfredo Berruti, Francesca Spada, et al.
Biomedicines|August 29, 2024
Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational ResearchVeronica Giusti, Giacomo Miserocchi, Giulia Sbanchi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial)Giuseppe Lombardi, Paola Del Bianco, Alba A Brandes, et al.
Skeletal Radiology|May 7, 2024
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcomaAyano Aso, Hisaki Aiba, Matteo Traversari, et al.
Scientific Reports|February 23, 2021
First prospective data on breast cancer patients from the multicentre italian bone metastasis databaseAlberto Bongiovanni, Flavia Foca, Manuela Fantini, et al.
Journal of Clinical Medicine|November 9, 2019
BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center "Real-Life" Experience (BOHEME Study)Federica Recine, Alberto Bongiovanni, Flavia Foca, et al.
International Journal of Molecular Sciences|April 28, 2023
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical NeedSilvia Vanni, Valentina Fausti, Eugenio Fonzi, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
Nanoscale|March 21, 2025
Engineered anti-HER2 drug delivery nanosystems for the treatment of breast cancerSilvia Vanni, Tania Mariastella Caputo, Angela Maria Cusano, et al.
Cancers|January 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center ExperienceAlessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra, et al.
Tumori|August 20, 2009
Multidisciplinary approach to the treatment of bone metastases: Osteo-Oncology Center, a new organizational modelToni Ibrahim, Emanuela Flamini, Laura Fabbri, et al.
Neuroendocrinology|August 31, 2022
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT StudyPiero Ferolla, Alfredo Berruti, Francesca Spada, et al.
Biomedicines|August 29, 2024
Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational ResearchVeronica Giusti, Giacomo Miserocchi, Giulia Sbanchi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial)Giuseppe Lombardi, Paola Del Bianco, Alba A Brandes, et al.
Skeletal Radiology|May 7, 2024
A reduction in tumor volume exceeding 65% predicts a good histological response to neoadjuvant chemotherapy in patients with Ewing sarcomaAyano Aso, Hisaki Aiba, Matteo Traversari, et al.
Scientific Reports|February 23, 2021
First prospective data on breast cancer patients from the multicentre italian bone metastasis databaseAlberto Bongiovanni, Flavia Foca, Manuela Fantini, et al.
Journal of Clinical Medicine|November 9, 2019
BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center "Real-Life" Experience (BOHEME Study)Federica Recine, Alberto Bongiovanni, Flavia Foca, et al.
International Journal of Molecular Sciences|April 28, 2023
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical NeedSilvia Vanni, Valentina Fausti, Eugenio Fonzi, et al.
Pageof 23